Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period SM Kissler, C Tedijanto, E Goldstein, YH Grad, M Lipsitch Science 368 (6493), 860-868, 2020 | 3026 | 2020 |
BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting N Dagan, N Barda, E Kepten, O Miron, S Perchik, MA Katz, MA Hernán, ... New England Journal of Medicine 384 (15), 1412-1423, 2021 | 2770 | 2021 |
Transmission dynamics and control of severe acute respiratory syndrome M Lipsitch, T Cohen, B Cooper, JM Robins, S Ma, L James, ... science 300 (5627), 1966-1970, 2003 | 1870 | 2003 |
Defining the epidemiology of Covid-19—studies needed M Lipsitch, DL Swerdlow, L Finelli New England journal of medicine 382 (13), 1194-1196, 2020 | 1689 | 2020 |
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China JT Wu, K Leung, M Bushman, N Kishore, R Niehus, PM de Salazar, ... Nature medicine 26 (4), 506-510, 2020 | 1649 | 2020 |
Covid-19 breakthrough infections in vaccinated health care workers M Bergwerk, T Gonen, Y Lustig, S Amit, M Lipsitch, C Cohen, ... New England Journal of Medicine 385 (16), 1474-1484, 2021 | 1448 | 2021 |
How generation intervals shape the relationship between growth rates and reproductive numbers J Wallinga, M Lipsitch Proceedings of the Royal Society B: Biological Sciences 274 (1609), 599-604, 2007 | 1397 | 2007 |
Negative controls: a tool for detecting confounding and bias in observational studies M Lipsitch, ET Tchetgen, T Cohen Epidemiology 21 (3), 383-388, 2010 | 1257 | 2010 |
Serotype replacement in disease after pneumococcal vaccination DM Weinberger, R Malley, M Lipsitch The Lancet 378 (9807), 1962-1973, 2011 | 1084 | 2011 |
Transmissibility of 1918 pandemic influenza CE Mills, JM Robins, M Lipsitch Nature 432 (7019), 904-906, 2004 | 1024 | 2004 |
Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting N Barda, N Dagan, Y Ben-Shlomo, E Kepten, J Waxman, R Ohana, ... New England Journal of Medicine 385 (12), 1078-1090, 2021 | 1021 | 2021 |
Public health interventions and epidemic intensity during the 1918 influenza pandemic RJ Hatchett, CE Mecher, M Lipsitch Proceedings of the National Academy of Sciences 104 (18), 7582-7587, 2007 | 964 | 2007 |
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study N Barda, N Dagan, C Cohen, MA Hernán, M Lipsitch, IS Kohane, BY Reis, ... The Lancet 398 (10316), 2093-2100, 2021 | 920 | 2021 |
Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection R Malley, P Henneke, SC Morse, MJ Cieslewicz, M Lipsitch, ... Proceedings of the National Academy of Sciences 100 (4), 1966-1971, 2003 | 909 | 2003 |
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus KM Bubar, K Reinholt, SM Kissler, M Lipsitch, S Cobey, YH Grad, ... Science 371 (6352), 916-921, 2021 | 837 | 2021 |
Absolute humidity and the seasonal onset of influenza in the continental United States J Shaman, VE Pitzer, C Viboud, BT Grenfell, M Lipsitch PLoS biology 8 (2), e1000316, 2010 | 795 | 2010 |
Antibiotics in agriculture and the risk to human health: how worried should we be? Q Chang, W Wang, G Regev‐Yochay, M Lipsitch, WP Hanage Evolutionary applications 8 (3), 240-247, 2015 | 702 | 2015 |
Antimicrobial use and antimicrobial resistance: a population perspective M Lipsitch, MH Samore Emerging infectious diseases 8 (4), 347, 2002 | 647 | 2002 |
Evaluating treatment protocols to prevent antibiotic resistance S Bonhoeffer, M Lipsitch, BR Levin Proceedings of the National Academy of Sciences 94 (22), 12106-12111, 1997 | 585 | 1997 |
Interleukin-17A mediates acquired immunity to pneumococcal colonization YJ Lu, J Gross, D Bogaert, A Finn, L Bagrade, Q Zhang, JK Kolls, ... PLoS pathogens 4 (9), e1000159, 2008 | 568 | 2008 |